For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...

The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

Operator Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...